Literature DB >> 11264240

Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.

C Ribas1, A Miralles, X Busquets, J A García-Sevilla.   

Abstract

1. This study was designed to assess the molecular and cellular events involved in the up-regulation (and receptor supersensitivity) of brain alpha(2)-adrenoceptors as a result of chronic depletion of noradrenaline (and other monoamines) by reserpine. 2. Chronic reserpine (0.25 mg kg(-1) s.c., every 48 h for 6 - 14 days) increased significantly the density (B(max) values) of cortical alpha(2)-adrenoceptor agonist sites (34 - 48% for [(3)H]-UK14304, 22 - 32% for [(3)H]-clonidine) but not that of antagonist sites (11 - 18% for [(3)H]-RX821002). Competition of [(3)H]-RX821002 binding by (-)-adrenaline further indicated that chronic reserpine was associated with up-regulation of the high-affinity state of alpha(2)-adrenoceptors. 3. In cortical membranes of reserpine-treated rats (0.25 mg kg(-1) s.c., every 48 h for 20 days), the immunoreactivities of various G proteins (Galphai(1/2), Galphai(3), Galphao and Galphas) were increased (25 - 34%). Because the high-affinity conformation of the alpha(2)-adrenoceptor is most probably related to the complex with Galphai(2) proteins, these results suggested an increase in signal transduction through alpha(2)-adrenoceptors (and other monoamine receptors) induced by chronic reserpine. 4. After alpha(2)-adrenoceptor alkylation, the analysis of receptor recovery (B(max) for [(3)H]-UK14304) indicated that the increased density of cortical alpha(2)-adrenoceptors in reserpine-treated rats was probably due to a higher appearance rate constant of the receptor ((Delta)r=57%) and not to a decreased disappearance rate constant ((Delta)k=7%). 5. Northern- and dot-blot analyses of RNA extracted from the cerebral cortex of saline- and reserpine-treated rats (0.25 mg kg(-1), s.c., every 48 h for 20 days) revealed that reserpine markedly increased the expression of alpha(2a)-adrenoceptor mRNA in the brain (125%). This transcriptional activation of the receptor gene expression appears to be the cellular mechanism by which reserpine induces up-regulation in the density of brain alpha(2)-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264240      PMCID: PMC1572698          DOI: 10.1038/sj.bjp.0703963

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  55 in total

1.  alpha 2-Adrenergic receptors appear in rat salivary glands after reserpine treatment.

Authors:  D B Bylund; J R Martinez
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

2.  Alpha 2-adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections.

Authors:  B Grijalba; L F Callado; J Javier Meana; J A García-Sevilla; A Pazos
Journal:  Eur J Pharmacol       Date:  1996-08-22       Impact factor: 4.432

3.  Effects of chronically administered antidepressants and electroconvulsive treatment on cerebral neurotransmitter receptors in rodents with 'model depression'.

Authors:  J Vetulani; L Antkiewicz-Michaluk; A Rokosz-Pelc; J Michaluk
Journal:  Ciba Found Symp       Date:  1986

4.  Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims.

Authors:  L F Callado; J J Meana; B Grijalba; A Pazos; M Sastre; J A García-Sevilla
Journal:  J Neurochem       Date:  1998-03       Impact factor: 5.372

5.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

6.  Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study.

Authors:  A P Nicholas; V Pieribone; T Hökfelt
Journal:  J Comp Neurol       Date:  1993-02-22       Impact factor: 3.215

Review 7.  Antidepressants and the brain.

Authors:  P Delgado; F Moreno
Journal:  Int Clin Psychopharmacol       Date:  1999-05       Impact factor: 1.659

8.  Spontaneous withdrawal from long-term treatment with morphine accelerates the turnover of alpha 2-adrenoceptors in the rat brain: up-regulation of receptors associated with increased receptor appearance.

Authors:  A M Gabilondo; J A García-Sevilla
Journal:  J Neurochem       Date:  1995-06       Impact factor: 5.372

9.  Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims.

Authors:  A M González; J Pascual; J J Meana; F Barturen; C del Arco; A Pazos; J A García-Sevilla
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

10.  Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats.

Authors:  I Ulibarri; J A García-Sevilla; L Ugedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

View more
  9 in total

1.  Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults.

Authors:  L Charles Murrin; Jeff D Sanders; David B Bylund
Journal:  Biochem Pharmacol       Date:  2007-01-25       Impact factor: 5.858

2.  Changes in the mRNA levels of α2A and α2C adrenergic receptors in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.

Authors:  Amal Alachkar; Jonathan M Brotchie; Owen T Jones
Journal:  J Mol Neurosci       Date:  2011-05-12       Impact factor: 3.444

3.  Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats.

Authors:  Magdalena Kozielska; Martin Johnson; Venkatesh Pilla Reddy; An Vermeulen; Cheryl Li; Sarah Grimwood; Rik de Greef; Geny M M Groothuis; Meindert Danhof; Johannes H Proost
Journal:  Pharm Res       Date:  2012-03-22       Impact factor: 4.200

4.  Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development.

Authors:  J D Sanders; H K Happe; D B Bylund; L C Murrin
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

5.  Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

Authors:  Sudhirkumar U Yanpallewar; Kimberly Fernandes; Swananda V Marathe; Krishna C Vadodaria; Dhanisha Jhaveri; Karen Rommelfanger; Uma Ladiwala; Shanker Jha; Verena Muthig; Lutz Hein; Perry Bartlett; David Weinshenker; Vidita A Vaidya
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

6.  Cellular consequences of stress and depression.

Authors:  Eberhard Fuchs; Gabriele Flügge
Journal:  Dialogues Clin Neurosci       Date:  2004-06       Impact factor: 5.986

7.  Opposing effects of α2- and β-adrenergic receptor stimulation on quiescent neural precursor cell activity and adult hippocampal neurogenesis.

Authors:  Dhanisha J Jhaveri; Ishira Nanavaty; Boris W Prosper; Swanand Marathe; Basma F A Husain; Steven G Kernie; Perry F Bartlett; Vidita A Vaidya
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

8.  Radioligand binding analysis of α 2 adrenoceptors with [11C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding.

Authors:  Jenny-Ann Phan; Anne M Landau; Steen Jakobsen; Dean F Wong; Albert Gjedde
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

9.  Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions.

Authors:  Roudabeh Vakil Monfared; Wedad Alhassen; Tri Minh Truong; Michael Angelo Maglalang Gonzales; Vincent Vachirakorntong; Siwei Chen; Pierre Baldi; Olivier Civelli; Amal Alachkar
Journal:  Cells       Date:  2021-10-31       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.